150 related articles for article (PubMed ID: 28410699)
1. Anaphylaxis to rifampicin and pyrazinamide in a child with tuberculous meningitis: A case report.
Nadri G; Taneja S; Singh V; Mittal P
Indian J Tuberc; 2017 Apr; 64(2):144-146. PubMed ID: 28410699
[TBL] [Abstract][Full Text] [Related]
2. [A case of tuberculous meningitis complicated with multiple drug hypersensitivity to antituberculosis agents].
Arai M
Rinsho Shinkeigaku; 2015; 55(2):123-5. PubMed ID: 25746078
[TBL] [Abstract][Full Text] [Related]
3. [Fulminant hepatitis during the therapy for tuberculous meningitis].
Garavelli PL
Recenti Prog Med; 1996 Dec; 87(12):597. PubMed ID: 9102699
[No Abstract] [Full Text] [Related]
4. Pyrazinamide-induced anaphylaxis: diagnosed by skin test and successful desensitization.
Bavbek S; Yılmaz I; Aydın Ö; Ozdemir SK
Int Arch Allergy Immunol; 2012; 157(2):209-12. PubMed ID: 21986254
[TBL] [Abstract][Full Text] [Related]
5. [Anti-tuberculosis chemotherapy and management of adverse reactions].
Kuwabara K
Nihon Rinsho; 2011 Aug; 69(8):1389-93. PubMed ID: 21838035
[TBL] [Abstract][Full Text] [Related]
6. [Isoniazid-induced hepatic failure. Report of a case].
Pereira RM; Tresoldi AT; Hessel G
Arq Gastroenterol; 2000; 37(1):72-5. PubMed ID: 10962632
[TBL] [Abstract][Full Text] [Related]
7. Adverse reactions to drugs used in the treatment of tuberculosis.
Nariman S
Adverse Drug React Acute Poisoning Rev; 1988; 7(4):207-27. PubMed ID: 3071113
[No Abstract] [Full Text] [Related]
8. [Allergy to antitubercular agents; with special reference to new drugs].
Mühlberger F
Schweiz Med Wochenschr; 1973 Jan; 103(4):126-31. PubMed ID: 4119096
[No Abstract] [Full Text] [Related]
9. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
10. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
[TBL] [Abstract][Full Text] [Related]
11. Management of paradoxical response in pediatric tubercular meningitis with methylprednisolone.
Nema N; Verma A; Singh K; Mehar V
Middle East Afr J Ophthalmol; 2014; 21(2):189-92. PubMed ID: 24791114
[TBL] [Abstract][Full Text] [Related]
12. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
[TBL] [Abstract][Full Text] [Related]
13. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Rifampin in tuberculous meningitis.
Sifontes JE
J Pediatr; 1975 Dec; 87(6 Pt 1):1015-7. PubMed ID: 1185383
[No Abstract] [Full Text] [Related]
15. [Adverse reactions to short-course anti-tuberculous therapy (author's transl)].
Carrasco E
Rev Med Chil; 1981 Jun; 109(6):566-72. PubMed ID: 7330536
[No Abstract] [Full Text] [Related]
16. PZA hypersensitivity.
Shorr AF; Trotta RF
Chest; 1996 Mar; 109(3):855-6. PubMed ID: 8617112
[No Abstract] [Full Text] [Related]
17. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Apr; 50(15):289-91. PubMed ID: 11330495
[TBL] [Abstract][Full Text] [Related]
18. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
19. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
Garca-Doval I
J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics of pyrazinamide during the initial phase of tuberculous meningitis treatment.
Stemkens R; Litjens CHC; Dian S; Ganiem AR; Yunivita V; van Crevel R; Te Brake LHM; Ruslami R; Aarnoutse RE
Int J Antimicrob Agents; 2019 Sep; 54(3):371-374. PubMed ID: 31202922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
